Increase in vertebral fracture risk in postmenopausal women using omeprazole

Calcified Tissue International

Volumn 84, Issue 1, 2009, Pages 13-19

  Roux, Christian ^a   Briot, Karine ^a   Gossec, Laure ^a   Kolta, Sami ^a   Blenk, Tilo ^b   Felsenberg, Dieter ^b   Reid, David M ^c   Eastell, Richard ^d   Glüer, Claus C ^e  

^a Paris Descartes University ^*  (France)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Osteoporosis; Postmenopausal women; Proton pump inhibitor; Vertebral fracture

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; BONE DENSITY; CASE CONTROL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; GASTROESOPHAGEAL REFLUX; HIP FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POPULATION; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STOMACH DISEASE; ULTRASOUND; VERTEBRA FRACTURE; X RAY;

AGED; ANTI-ULCER AGENTS; ESOPHAGEAL DISEASES; EUROPE; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OMEPRAZOLE; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RISK FACTORS; SPINAL FRACTURES; STOMACH DISEASES;

EID: 58149279436     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-008-9188-4     Document Type: Article

References (49)

1. BC Jacobson TG Ferris TL Shea EM Mahlis TH Lee TC Wang 2003 Who is using chronic acid suppression therapy and why? Am J Gastroenterol 98 51 58
2. CJ Hawkey JA Karrasch L Szczepanski DG Walker A Barkun AJ Swannel 1998 Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs N Engl J Med 338 727 734
3. ND Yeomans Z Tulassay L Juhasz I Racz JM Howard J Van Rensburg 1998 A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs N Engl J Med 338 719 726
4. FKL Chan LCT Hung BY Suen JCY Wu KC Lee AJ Hui 2002 Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis N Engl J Med 347 2104 2110
5. P Ekström L Carling S Wetterhus PE Wingren O Anker-Hansen G Lundegardh 1996 Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continous non-steroidal anti-inflammatory drug therapy. A nordic multicentre study Scand J Gastroenterol 31 753 758
6. D Cullen KD Bardhan M Eisner DG Kogut RA Peacock JM Thomson 1998 Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users Aliment Pharmacol Ther 12 135 140
7. W Smalley CM Stein PG Arbogast G Eisen WA Ray M Griffin 2002 Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs Arthritis Rheum 46 2195 2200
8. KC Lai SK Lam KM Chu BC Wong WM Hui WH Hu 2002 Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use N Engl J Med 346 2033 2038
9. EE Roughead K McGeechan GP Sayer 2004 Bisphosphonates use and subsequent prescription of acid suppressants Br J Clin Pharmacol 57 813 816
10. +-ATPase Curr Pharm Des 8 2033 2048
11. +-ATPase inhibits bone resorption in vitro Calcif Tissue Int 38 123 125
12. --ATPase, on bone resorption in humans Calcif Tissue Int 53 21 25
13. R Baron L Neff D Louvard PJ Courtoy 1985 Cell-mediated extra-cellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of 100kD lysosomal membrane protein at the osteoclast ruffled border J Cell Biol 101 2110 2222
14. +-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats J Clin Invest 106 309 318
15. 2 receptor antagonists, and other antacid medications and the risk of fracture Calcif Tissue Int 79 76 83
16. YN Yang JD Lewis S Epstein DC Metz 2006 Long-term proton pump inhibitor therapy and risk of hip fracture JAMA 296 2947 2953
17. R Burge B Dawson-Hughes DH Solomon JB Wong A King A Tosteson 2007 Incidence and economic burden of osteoporosis-related fractures in the United States 2005-2015 J Bone Miner Res 22 465 475
18. CC Glüer R Eastell DM Reid D Felsenberg C Roux R Barkmann 2004 Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study J Bone Miner Res 19 782 793
19. TW O'Neill C Cooper JB Cannata JB Diaz Lopez K Hoszowski O Johnell 1994 Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: the European Vertebral Osteoporosis Study Int J Epidemiol 23 559 565
20. +-translocating ATPases Biochim Biophys Acta 1065 261 268
21. +-ATPase d2 subunit: molecular characterization, developmental regulation, and localization to specialized proton pumps in kidney and bone J Am Soc Nephrol 16 1245 1256
22. K Niikura M Takano M Sawada 2004 A novel inhibitor of vacuolar ATPase, FR167356, can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase Br J Pharmacol 142 558 566
23. Yu EW, Shinoff C, Blackwell T, Ensrud K, Hillier T, Bauer DC (2006) Use of acid-suppressive medications and risk of bone loss and fracture in postmenopausal women. J Bone Miner Res 21(Suppl 1):S281
24. O Chonan R Takahashi H Yasui M Watanuki 1998 Effect of L-lactic acid on calcium absorption in rats fed omeprazole J Nutr Sci Vitaminol 44 473 481
25. MB O'Connell DM Madden AM Murray RP Heaney U Kerzner 2005 Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial Am J Med 118 778 781
26. G Graziani G Como S Badalamenti S Finazzi A Malesci M Gallieni 1995 Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects Nephrol Dial Transplant 10 1376 1380
27. C Serfaty-Lacrosniere RJ Wood D Voytko JR Saltzman M Pedrosa TE Sepe 1995 Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans J Am Coll Nutr 14 364 368
28. RG Cumming 1990 Calcium intake and bone mass: a quantitative review of the evidence Calcif Tissue Int 47 194 201
29. 3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or vitamin D, RECORD): a randomised placebo-controlled trial Lancet 365 1621 1628
30. RD Jackson AZ Lacroix M Gass RB Wallace J Robbins CE Lewis 2006 Calcium plus vitamin D supplementation and the risk of fracture N Engl J Med 354 669 683
31. H Koop 1992 Metabolic consequences of long-term inhibition of acid secretion by omeprazole Aliment Pharmacol Ther 6 399 406
32. 12 is associated with lower BMD: the Framingham Osteoporosis Study J Bone Miner Res 20 152 158
33. JB Goerss CH Kim EJ Atkinson R Eastell WM O'Fallon LJ Melton 3rd 1992 Risk of fractures in patients with pernicious anemia J Bone Miner Res 7 573 579
34. RR McLean PF Jacques J Selhub 2004 Homocysteine as a predictive factor for hip fracture in older persons N Engl J Med 350 2042 2049
35. AT Hostmark 2003 Dietary acid load and self reported prevalence of hip fractures: a population based cross sectional study Norsk Epidemiologi 13 193 198
36. Henriksen DB, Hartman B, Jeppesen PB, Miholic J, Christiansen C, Holst JJ (2004) The postprandial bone resorption process is regulated by gastrointestinal signal. J Bone Miner Res 19(Suppl 1):S92
37. N Figura L Gennari D Merlotti C Lenzi S Campagna B Franci 2005 Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls Dig Dis Sci 5 847 852
38. M Campbell-Thompson KK Reyher LB Wilkinson 2001 Immunolocalization of estrogen receptor alpha and beta in gastric epithelium and enteric neurons J Endocrinol 171 65 73
39. T Ueyama N Shirasawa M Numazawa K Yamada M Shelangouski T Ito 2002 Gastric parietal cells: potent endocrine role in secreting estrogen as a possible regulator of gastro-hepatic axis Endocrinology 143 3162 3170
40. M Sozzi M Valentini N Figura P De Paoli RM Tedeschi A Gloghini 1998 Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status Am J Gastroenterol 93 375 379
41. I Sakata T Tanaka M Yamazaki T Tanizaki Z Zheng T Sakai 2006 Gastric estrogen directly induces ghrelin expression and production in the rat stomach J Endocrinol 190 749 757
42. N Fukushima R Hanada H Teranishi Y Fukue T Tachibana H Ishikawa 2005 Ghrelin directly regulates bone formation J Bone Miner Res 20 790 798
43. LA Weiss C Langenberg E Barrett-Connor 2006 Ghrelin and bone: is there an association in older adults? The Rancho Bernardo Study J Bone Miner Res 21 752 757
44. 2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model J Cell Physiol 173 10 18
45. 2 receptor antagonist cimetidine Bone 30 131 136
46. 2-receptor antagonist Calcif Tissue Int 62 283 285
47. JA Grisso JL Kelsey LA O'Brien CG Miles S Sidney G Maislin 1997 Risk factors for hip fracture in men Hip Fracture Study Group Am J Epidemiol 145 786 793
48. LE Targownik LM Lix CJ Metge HJ Prior S Leung WD Leslie 2008 Use of proton pump inhibitors and risk of osteoporosis-related fractures CMAJ 179 319 326
49. de Vries F, Cooper A, Logan R, Cockle S, van Staa T, Cooper C (2007) Fracture risk in patients receiving concomitant bisphosphonate and acid-suppressive medication or bisphosphonate alone. Osteoporos Int 18(Suppl 3):S261